Aprecia Pharmaceuticals Revenue, Growth & Competitor Profile

DBA APRECIA PHARMACEUTICALS CORP

Company Profile & Annual Report for Aprecia Pharmaceuticals

Access the complete profile.

Aprecia Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	10901 Kenwood Rd Blue Ash, OH 45242

Note: Revenues for privately held companies are statistical evaluations.


Aprecia Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Aprecia Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Aprecia Pharmaceuticals is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Aprecia Pharmaceuticals Annual Revenue and Growth Rate

Aprecia Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Aprecia Pharmaceuticals's revenues are gauged from an analysis of company filings.

Aprecia Pharmaceuticals's Income Statement (based on Industry Averages)

Aprecia Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Aprecia Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 28, 2016	20	94%	$84 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Aprecia Pharmaceuticals is developing and marketing. Aprecia Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
INFINIDOSE Pharmaceutical manufacturing services	01/19/2024
Z-FREE Pharmaceutical manufacturing services	01/05/2024
Z-FORM Pharmaceutical manufacturing services	01/05/2024

See all trademarks and details in the Full Report.

Market Share of Aprecia Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Aprecia Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Aprecia Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
KEYSOURCE ACQUISITION	Cincinnati, OH	100
APRECIA PHARMACEUTICALS	Blue Ash, OH	61
HUTCHESON HOMECARE PHARMACY	Cincinnati, OH	13
SCHWARTZ LABORATORIES	Cincinnati, OH	2

Future Competition: Aprecia Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Aprecia Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)